Gene · 432
Papers2,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicles of patients with acute-on-chronic liver failure induce mitochondrial dysfunction in T cells. | Front Immunol | 2025 | 41058709 | PubTator, text mining | PubMed |
| Supramolecular Assembly of Graphene-Polyamine-PdS-CdS Photocatalysts for Synergistically Enhanced and Highly Effective Hydrogen Evolution from Water under Visible Light. | Inorg Chem | 2025 | 41054256 | PubTator, text mining | PubMed |
| Whole-Body Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling for Interspecies Translation and Mechanistic Characterization of Plasma and Tissue Disposition of GalNAc-siRNAs. | Pharmaceutics | 2025 | 41012491 | PubTator, text mining | PubMed |
| Rational design of the linkers in targeting chimeras. | Chem Sci | 2025 | 40988686 | PubTator, text mining | PubMed |
| Asialoglycoprotein receptor-1 mediated targeted drug delivery to liver cancer cells using stimuli responsive galactosylated electrospun nanofibers. | Int J Biol Macromol | 2025 | 40975359 | PubTator, text mining | PubMed |
| Optimizing mucosal vaccination: Exploiting Lactobionic acid-modified chitosan for superior gene delivery systems. | Int J Biol Macromol | 2025 | 40915467 | PubTator, text mining | PubMed |
| Dual functionality of MDM2 in PROTACs expands the horizons of targeted protein degradation. | Biomark Res | 2025 | 40866949 | PubTator, text mining | PubMed |
| Asialoglycoprotein receptor 1: a multifaceted receptor in the liver and cardiovascular system. | Front Med (Lausanne) | 2025 | 40852369 | PubTator, text mining | PubMed |
| Development of novel high-throughput biochemical competition assays to identify ligands of human asialoglycoprotein receptor 1. | SLAS Discov | 2025 | 40848739 | PubTator, text mining | PubMed |
| PCSK9 targeting therapies for familial hypercholesterolaemia: a meta-analysis of efficacy on lipid biomarkers and safety in adults and children across 23 RCTs. | Open Heart | 2025 | 40841123 | PubTator, text mining | PubMed |
| Major depressive disorder and anti-depressant therapy markedly alters the human follicular niche DNA methylome. | Reproduction | 2025 | 40834902 | PubTator, text mining | PubMed |
| Plasma proteomic signatures of social support and their association with cardiovascular disease and mortality. | medRxiv | 2025 | 40832392 | PubTator, text mining | PubMed |
| Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives. | Eur J Med Res | 2025 | 40826140 | PubTator, text mining | PubMed |
| Chimerolectins: Classification, structural architecture, and functional perspectives. | Protein Sci | 2025 | 40815298 | PubTator, text mining | PubMed |
| Forsythoside B and Its Derivatives as Novel ASGR1 Inhibitors for Enhanced Cholesterol Efflux. | Chem Biodivers | 2025 | 40768748 | PubTator, text mining | PubMed |
| Liver-targeted degradation of BRD4 reverses hepatic fibrosis and enhances metabolism in murine models. | Theranostics | 2025 | 40756370 | PubTator, text mining | PubMed |
| From laboratory to clinic: a precise treatment strategy of mesenchymal stem cells-derived exosomes pretreated by simulating disease microenvironment. | Front Immunol | 2025 | 40746527 | PubTator, text mining | PubMed |
| Direct interaction of HMGB1 with SARS-CoV-2 facilitates its infection via RAGE-dependent endocytosis. | iScience | 2025 | 40740486 | PubTator, text mining | PubMed |
| Dissecting the Hepatitis B Virus Replication Mechanisms and Advances in in vivo Models: A Comprehensive Review. | Dig Dis | 2025 | 40706577 | PubTator, text mining | PubMed |
| Isolation and Whole Genome Sequence Analysis of Alcaligenes and Chromobacterium Strains with Antimicrobial Activity Against ESKAPE Pathogen Relatives. | J Genomics | 2025 | 40672116 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/432/papers?page=7